Диссертация (1140160), страница 25
Текст из файла (страница 25)
// Mol Med Rep. 2014Jul;10(1):3-9.147.Krakowsky RH, Tollefsbol TO // Impact of Nutrition on Non-CodingRNA Epigenetics in Breast and Gynecological Cancer.// Front Nutr. 2015 May 27;2:16192148.Kulasingam S, Havrilesky L, Ghebre R, Myers E. Screening for Cervical Cancer:A Decision Analysis for the U.S. Preventive Services Task Force. Rockville, MD: Agency forHealthcare Research and Quality; 2011. AHRQ Publication No.11-05157-EF-1.149.Kuppusamy SP, Kaiser JP, Wesselkamper SC // Epigenetic Regulation inEnvironmental Chemical Carcinogenesis and its Applicability in Human Health RiskAssessment.
// Int J Toxicol. 2015 Aug 12. pii: 1091581815599350.150.Kwon HJ, Kim MS, Kim MJ, Nakajima H, Kim KW. Histone deacetylaseinhibitor FK228 inhibits tumor angiogenesis. Int J Cancer.2001;97:290–296.151.Lakshmaiah KC, Jacob LA, Aparna S, Lokanatha D, Saldanha SC.
// Epigenetictherapy of cancer with histone deacetylase inhibitors. // J Cancer Res Ther. 2014 JulSep;10(3):469-78.152.Le JM, Squarize CH, Castilho RM // Histone modifications: Targeting headand neck cancer stem cells // World J Stem Cells. 2014 Nov 26;6(5):511-25.153.Lechner M, Fenton T, West J, Wilson G, Feber A, Henderson S, Thirlwell C,Dibra HK, Jay A, Butcher L, Chakravarthy AR, Gratrix F, Patel N, Vaz F, O'Flynn P,Kalavrezos N, Teschendorff AE, Boshoff C, Beck S. Identifi cation and functional validationof HPV-mediated hypermethylation in head and neck squamous cell carcinoma.
GenomeMed. 2013;5:15.154.Lei WW, Zhang KH, Pan XC, Wang DM, Hu Y, Yang YN. et al. Histonedeacetylase 1 and 2 differentially regulate apoptosis by opposing effects on extracellularsignal-regulated kinase 1/2. Cell Death Dis.2010;1:e44.155.Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Humanpapillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation bygeographical region, histological type and year of publication. Int J Cancer 2011;128:927Y35.156.Li X, Li L, Pandey R, Byun JS, Gardner K, Qin Z, Dou Y. The histoneacetyltransferase MOF is a key regulator of the embryonic stem cell core transcriptionalnetwork. Cell Stem Cell. 2012;11:163–178.157.Lin Z, Bazzaro M, Wang MC, Chan KC, Peng S, Roden RB.
Combination ofproteasome and HDAC inhibitors for uterine cervical cancer treatment.// Clin CancerRes. 2009 Jan 15;15(2):570-7.193158.LiuD, ZhouP, ZhangL, GongW, HuangG, ZhengY, HeF.//HDAC1/DNMT3A-containing complex is associated with suppression of Oct4 in cervicalcancer cells.// Biochemistry (Mosc). 2012 Aug;77(8):934-40.159.Liu N, Zhao LJ, Li XP, Wang JL, Chai GL, Wei LH.// Histone deacetylaseinhibitors inducing human cervical cancer cell apoptosis by decreasing DNAmethyltransferase 3B.// Chin Med J (Engl).
2012 Sep;125(18):3273-8.160.Lu Q, Ma D, Zhao S. // DNA methylation changes in cervical cancers.// MethodsMol Biol. 2012;863:155-76161.Ma P, Pan H, Montgomery RL, Olson EN, Schultz RM. Compensatory functionsof histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis duringmouse oocyte development.Proc Natl Acad Sci U S A. 2012;109:E481–E489.162.MacAlpine DM, Almouzni G. Chromatin and DNA replication.
Cold SpringHarb Perspect Biol. 2013;5:a010207.163.MarshDJ, ShahJS, ColeAJ//Histones andtheirmodificationsinovarian cancer - drivers of disease and therapeutic targets. // Front Oncol. 2014 Jun 12;4:144.164.Martin-HirschPP, ParaskevaidisE, BryantA, DickinsonHO.Surgery for cervical intraepithelial neoplasia. // Cochrane Database Syst Rev. 2013 Dec4;12:CD001318.165.McCormack E, Haaland I, Venas G, Forthun RB, Huseby S, Gausdal G.
et al.Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloidleukemia. Leukemia. 2012;26:910–7.166.Melnikow J, McGahan C, Sawaya GF, Ehlen T, Coldman A. Cervicalintraepithelial neoplasia outcomes after treatment: long-term follow-up from the BritishColumbia Cohort Study.
J Natl Cancer Inst 2009;101:721Y8.167.Micelli C, Rastelli G // Histone deacetylases: structural determinants of inhibitorselectivity.// Drug Discov Today. 2015 Jun;20(6):718-35. doi: 10.1016/j.drudis.2015.01.007.Epub 2015 Feb 14.168.Milavetz B, Kallestad L, Gefroh A, Adams N, Woods E, Balakrishnan L. Virion-mediated transfer of SV40 epigenetic information. Epigenetics. 2012;7:528–534. [PMC freearticle]194169.MilavetzBI, BalakrishnanL.//Viral epigenetics.//MethodsMolBiol. 2015;1238:569-96.170.MillerMG,SungHY,SawayaGF,KearneyKA,Kinney W, Hiatt RA. Screeninginterval and risk of invasive squamous cell cervical cancer. Obstet Gynecol 2003;101:29Y37.171.Minucci S, Pelicci PG.
Histone deacetylase inhibitors and the promise ofepigenetic (and more) treatments for cancer. Nat Rev Cancer.2006;6:38–51.172.Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasiljevic N, WentzensenN, Herrero R, Hildesheim A, Wacholder S, Scibior-Bentkowska D, Burk RD, Lorincz AT.Elevated methylation of HPV16 DNA is associated with the development of high gradecervical intraepithelial neoplasia. Int J Cancer. 2013;132:1412–1422.173.Mosher WD, Chandra A, Jones J.
Sexual behavior and selected health measures:men and women 15Y44 years of age, United States, 2002. Adv Data. 2005:1Y55.174.Mottet D, Bellahcène A, Pirotte S, Waltregny D, Deroanne C, Lamour V. et al.Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis.Circ Res. 2007;101:1237–1246175.Munoz N, Bosch FX, de Sanjose S, et al. Epidemio- logic classification of humanpapillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518Y27.176.Murta EF, Souza MA, Araújo Júnior E, Adad SJ.
Incidence of Gardnerellavaginalis, Candida sp and human papilloma virus in cytological smears. Sao Paulo MedJ. 2000 Jul 6;118(4):105-8.177.Nagar HA, Dobbs SP, McClelland HR, Price JH, McClean G, McCluggage WG.The large loop excision of the transformation zone cut or blend thermal artefact study: arandomized controlled trial. International Journal of Gynecological Cancer 2004; Vol. 14,issue 6:1108–11.178.Nuovo J, Melnikow J, Willan AR, Chan BK.// Treatment outcomes for squamousintraepithelial lesions. // Int J Gynaecol Obstet. 2000 Jan;68(1):25-33.179.Paraskevaidis E, ArbynM, SotiriadisA, DiakomanolisE, Martin-HirschP, Koliopoulos G, Makrydimas G, Tofoski J,Roukos DH.
// The role of HPV DNA testing inthe follow-up period after treatment for CIN: a systematic review of the literature. // CancerTreat Rev. 2004 Apr;30(2):205-11.195180.Park JY, Lee SM, Yoo CW et al. Risk factors predicting residual disease insubsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) IIIand microinvasive cervical cancer // Gynecol.Oncol. – 2007.- Vol.107(1).- P. 39-44.181.Parkin DM, Bray F.
Chapter 2: The burden of HPV- related cancers. Vaccine2006;24(suppl 3):S3/11Y25.182.Pathology and Genetics of Tumours of the Breast and Female Genital Organs(IARC WHO Classification of Tumours), Lyon 2003 , WHO 2003 г.183.Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital humanpapillomavirus detection in a US population. J Infect Dis 2001;183:1554Y64.184.Pisani P, Bray F, Parkin DM (2002).
Estimates of the world-wide prevalence ofcancer for 25 sites in the adult population. Int J Cancer, 97, 72-81185.Plummer M, Schiffman M, Castle PE, Maucort- Boulch D, Wheeler CM. A 2-year prospective study of human papillomavirus persistence among women with a cytologicaldiagnosis of atypical squamous cells of undetermined sig- nificance or low-grade squamousintraepithelial lesion. J Infect Dis 2007;195:1582Y9.186.Prato B, Ghelardi A, Gaducci A, Marchetti I. Correlation of recurrence rates andtimes with posttreatment human papillomavirus status in patients treated with loopelectrosurgical excision procedure conization for cervical intraepithelial lesions // Int.
J. ofGynecological Cancer. – 2008. – Vol. 8 (1). – P. 90-94.187.Qian DZ, Kachhap SK, Collis SJ, Verheul HM, Carducci MA, Atadja P. et al.Class II histone deacetylases are associated with VHL-independent regulation of hypoxiainducible factor 1 alpha.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
